Jørgen Hilden
Associate professor emeritus, Associate Professor emeritus
91 - 95 out of 95Page size: 10
- Published
Excess sudden cardiac deaths after short-term clarithromycin administration in the CLARICOR trial: why is this so, and why are statins protective?
Winkel, P., Hilden, Jørgen, Hansen, J. F., Hildebrandt, P., Kastrup, J., Kolmos, H. J., Kjøller, E., Jespersen, C. M., Gluud, C., Jensen, G. & CLARICOR Trial, G., 2011, In: Cardiology. 118, 1, p. 63-67Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10years in the CLARICOR randomised, blinded clinical trial
Winkel, P., Hilden, Jørgen, Hansen, J. F., Kastrup, J., Kolmos, H. J., Kjøller, E., Boje Jensen, G., Skoog, M., Lindschou, J., Gluud, C. & CLARICOR Trial Group, C. T. G., Mar 2015, In: International Journal of Cardiology. 182, p. 459-65 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Prognostic value of routinely available data in patients with stable coronary heart disease. A 10-year follow-up of patients sampled at random times during their disease course
Winkel, P., Jakobsen, J. C., Hilden, Jørgen, Jensen, G., Kjøller, E., Sajadieh, Ahmad, Kastrup, J., Kolmos, H. J., Larsson, A., Arnlov, J. & Gluud, C., 2018, In: Open Heart. 5, 2, 10 p., e000808.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease: A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial
Winkel, P., Jakobsen, J. C., Hilden, Jørgen, Jensen, G. B., Kjøller, E., Sajadieh, Ahmad, Kastrup, J., Kolmos, H. J., Iversen, Kasper, Bjerre, M., Larsson, A., Ärnlöv, J. & Gluud, C., 2020, In: BMJ Open. 10, 8, 7 p., e033720.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Cathepsin B and S as markers for cardiovascular risk and all-cause mortality in patients with stable coronary heart disease during 10 years: a CLARICOR trial sub-study
Wuopio, J., Hilden, Jørgen, Bring, C., Kastrup, J., Sajadieh, Ahmad, Jensen, G. B., Kjøller, E., Kolmos, H. J., Larsson, A., Jakobsen, J. C., Winkel, P., Gluud, C., Carlsson, A. C. & Ärnlöv, J., 2018, In: Atherosclerosis. 278, p. 97-102 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 314941
Most downloads
-
171
downloads
Pain relief that matters to patients: systematic review of empirical studies assessing the minimum clinically important difference in acute pain
Research output: Contribution to journal › Review › Research › peer-review
Published -
160
downloads
10-Year Associations Between Tumor Necrosis Factor Receptors 1 and 2 and Cardiovascular Events in Patients With Stable Coronary Heart Disease: A CLARICOR (Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease) Trial Substudy
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
148
downloads
Predictors for major cardiovascular outcomes in stable ischaemic heart disease (PREMAC): statistical analysis plan for data originating from the CLARICOR (clarithromycin for patients with stable coronary heart disease) trial
Research output: Contribution to journal › Journal article › Research › peer-review
Published